Study S001284

Effect of Tirzepatide on Diabetic Peripheral Sensorimotor Neuropathy: A Randomized, Open Label, Controlled Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07706088
Acronym: T-DPN
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 40
Start: 2026-07
Primary completion: 2028-07-01
Lead sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh
Conditions: Neuropathy, Small Fiber; Diabete Mellitus
Interventions: DRUG:Tirzepatide 2.5mg weekly; DRUG:all standard of care to diabetic patient besides tirzepatide
Results posted: FALSE

Registered primary outcomes

To assess the percent change in CNFD compared to baseline [6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.